1. Home
  2. Bills
  3. H.R. 8205

H.R. 8205 · 119th Congress · 2025–2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

H.R. 8205 in the 119th Congress (2025–2026) has passed both chambers — introduced on Apr 6, 2026, sponsored by Mike Quigley with 103 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Passed both chambers
Introduced
Apr 6, 2026
Co-sponsors
103
Policy area
Health

What it does

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Mike Quigley (D-IL). Co-sponsors: 64 Democrats, 39 Republicans.

Where it stands

  • IntroducedApr 6, 2026
  • Passed the HouseJul 22, 2026
  • Passed the SenateSep 28, 2026
  • Sent to the President—
  • Became law—

Latest action: Passed Senate without amendment by Voice Vote. (consideration: CR S5120) (Sep 28, 2026)

More bills from Mike Quigley in the 119th Congress

Other Health bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 8205 (119th Congress): Accelerating Access to Critical…,” https://www.capitolreceipts.com/bill/119-hr-8205/accelerating-access-to-critical-therapies-for-als-reauthorization-act (accessed 2026-10-17).